Akanda Corp. (AKAN)
Nasdaq: AKAN · Medicinal Chemicals & Botanical Products · New Romney, GB · filing with the SEC since 2021
Who owns Akanda Corp.
As filed with the SECHolders of 5% or more
0
No Schedule 13D or 13G naming this company is on file.
Directors and officers
0
report now, of 0 people on the record since 2026. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 0 named at left.
Holders of 5% or moreshare of the class, as filed
No holder of 5% or more is on file in a Schedule 13D or 13G naming this company.
What AKAN reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
CTFOMexico
An entity · subsidiary · owns, named in the 20-F filed Jun 9, 2026
CTMexico
An entity · subsidiary · owns, named in the 20-F filed Jun 9, 2026
RPKBiopharma Unipessoal Lda RPKMember
An entity · subsidiary · owns, named in the 20-F filed Jun 9, 2026
First Towers
A company bought · acquisition · owns, named in the 20-F filed Jun 9, 2026
2 subsidiaries in 1 country, from the list filed with the 20-F filed Apr 30, 2025.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
No open-market trade is on the record for these years.
Dollars as filed, summed by the transaction date.
People who traded in the window1 of 1 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Hrt Financial LP | 10% owner | 1 | $0 | 0 | 1 | $0 |